{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:31:56Z","timestamp":1794475916249,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cancer Policy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jcpo.2026.100792","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:56:52Z","timestamp":1786690612000},"page":"100792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Geographic disparities, trial characteristics, and transparency of 3720 ovarian cancer clinical trials"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5299-1308","authenticated-orcid":false,"given":"Xiu","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhonatan Medri","family":"Cobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1297-4622","authenticated-orcid":false,"given":"Henian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcpo.2026.100792_bib1","unstructured":"AmericanCancerSociety. Key statistics for ovarian cancer. 2026."},{"key":"10.1016\/j.jcpo.2026.100792_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","article-title":"Global epidemiology of epithelial ovarian cancer","volume":"21","author":"Webb","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jcpo.2026.100792_bib3","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian cancer: A review","volume":"334","author":"Caruso","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.jcpo.2026.100792_bib4","article-title":"Clinical trials and clinical research: A comprehensive review","volume":"15","author":"Kandi","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jcpo.2026.100792_bib5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12672-024-01195-7","article-title":"Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy","volume":"15","author":"Joshi","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.jcpo.2026.100792_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13048-018-0404-1","article-title":"Transparency in ovarian cancer clinical trial results: ClinicalTrials.gov versus PubMed, Embase and Google scholar","volume":"11","author":"Roberto","year":"2018","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.jcpo.2026.100792_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108437","article-title":"Research waste among randomized controlled trials in ovarian cancer: A cross-sectional study","volume":"50","author":"Lin","year":"2024","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.jcpo.2026.100792_bib8","article-title":"Characteristics and potential predictors of prematurely terminated interventional clinical trials for ovarian cancer in the ClinicalTrials.gov database","author":"Liu","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jcpo.2026.100792_bib9","unstructured":"NationalLibraryofMedicine. Trends and Charts on Registered Studies. 2026."},{"key":"10.1016\/j.jcpo.2026.100792_bib10","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/bcp.70023","article-title":"Investigating started sample size, completed sample size and drop-out rate in 10 252 phase III clinical trials: Insights from ClinicalTrials.gov","volume":"91","author":"Chen","year":"2025","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jcpo.2026.100792_bib11","article-title":"Breaking the silence of sharing data in medical research","volume":"19","author":"Chen","year":"2024","journal-title":"PLoS. One"},{"key":"10.1016\/j.jcpo.2026.100792_bib12","unstructured":"NationalLibraryofMedicine. ClinicalTrials.gov Glossary Terms. 2026."},{"key":"10.1016\/j.jcpo.2026.100792_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1559\/152304010792194930","article-title":"Bicomponent Trend Maps: A Multivariate Approach to Visualizing Geographic Time Series","volume":"37","author":"Schroeder","year":"2010","journal-title":"Cartogr. Geogr. Inf. Sci."},{"key":"10.1016\/j.jcpo.2026.100792_bib14","doi-asserted-by":"crossref","DOI":"10.5888\/pcd17.190254","article-title":"A Bivariate Mapping Tutorial for Cancer Control Resource Allocation Decisions and Interventions","volume":"17","author":"Biesecker","year":"2020","journal-title":"Prev. Chronic Dis."},{"key":"10.1016\/j.jcpo.2026.100792_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104307","article-title":"Patients' selection and trial matching in early-phase oncology clinical trials","volume":"196","author":"Corbaux","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jcpo.2026.100792_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2013.11.008","article-title":"Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper","volume":"132","author":"Herzog","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcpo.2026.100792_bib17","unstructured":"IQVIA Institute. Global Oncology Trends 2025: Adopting new therapies as modalities shift and expenditures rise. 2025."},{"key":"10.1016\/j.jcpo.2026.100792_bib18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7326\/M13-0480","article-title":"Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications","volume":"160","author":"Hartung","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jcpo.2026.100792_bib19","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/annonc\/mdw662","article-title":"Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours","volume":"28","author":"Leary","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jcpo.2026.100792_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/medicina57070647","article-title":"Blinding in Clinical Trials: Seeing the Big Picture","volume":"57","author":"Monaghan","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.jcpo.2026.100792_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.33972","article-title":"Evaluation of data sharing after implementation of the international committee of medical journal editors data sharing statement requirement","volume":"4","author":"Danchev","year":"2021","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.jcpo.2026.100792_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001950","article-title":"Sharing clinical trial data: a proposal from the international committee of medical journal editors","volume":"13","author":"Taichman","year":"2016","journal-title":"PLoS. Med."},{"key":"10.1016\/j.jcpo.2026.100792_bib23","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1126\/science.aba4456","article-title":"Time for NIH to lead on data sharing","volume":"367","author":"Sim","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jcpo.2026.100792_bib24","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/d41586-022-01692-1","article-title":"Many researchers say they'll share data - but don't","volume":"606","author":"Watson","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jcpo.2026.100792_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.104086","article-title":"Globalization of clinical trials in oncology: a worldwide quantitative analysis","volume":"10","author":"Izarn","year":"2025","journal-title":"ESMO Open."},{"key":"10.1016\/j.jcpo.2026.100792_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(19)33220-9","article-title":"Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study","volume":"395","author":"DeVito","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jcpo.2026.100792_bib27","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1002\/cam4.5385","article-title":"Early Termination of Oncology Clinical Trials in the United States","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.jcpo.2026.100792_bib28","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/s41588-024-01854-z","article-title":"Genetic factors associated with reasons for clinical trial stoppage","volume":"56","author":"Razuvayevskaya","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jcpo.2026.100792_bib29","article-title":"Why clinical trials are terminated","author":"Theodore","year":"2015","journal-title":"bioRxiv"},{"key":"10.1016\/j.jcpo.2026.100792_bib30","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/jama.2023.0875","article-title":"Disclosure of Possible Trial Termination to Participants of Interventional Clinical Trials","volume":"329","author":"Hutchinson","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jcpo.2026.100792_bib31","article-title":"Oncology clinical trial termination trends: Analysis across the prior 20 years","volume":"40","author":"Laura Palmeri","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jcpo.2026.100792_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/ijgc-2019-000851","article-title":"Clinical trial participation and aggressive care at the end of life in patients with ovarian cancer","volume":"30","author":"Nitecki","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jcpo.2026.100792_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ygyno.2023.05.066","article-title":"Disparities in clinical trial participation in ovarian cancer: A real-world analysis","volume":"175","author":"Smith","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcpo.2026.100792_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.47635","article-title":"Geographic Disparities in Gynecologic Oncology Clinical Trial Availability in the US","volume":"7","author":"Boland","year":"2024","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.jcpo.2026.100792_bib35","article-title":"Assessing populations with access to National Cancer Institute-funded sites using local distance-based service areas","volume":"9","author":"Shriver","year":"2025","journal-title":"J. Clin. Transl. Sci."}],"container-title":["Journal of Cancer Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538326000937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538326000937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:09:07Z","timestamp":1794474547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213538326000937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S2213538326000937"],"URL":"https:\/\/doi.org\/10.1016\/j.jcpo.2026.100792","relation":{},"ISSN":["2213-5383"],"issn-type":[{"value":"2213-5383","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geographic disparities, trial characteristics, and transparency of 3720 ovarian cancer clinical trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Cancer Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcpo.2026.100792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100792"}}